Infectious Disease

COVID-19 cases are surging across the country as the US heads into holiday season. Counsel patients on staying safe and keep these billing codes very close at hand.

Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.

The author was a young medical student when the first signs of the HIV epidemic appeared and it shaped his career. How will COVID-19 impact today's young clinicians?

Recent NIH COVID-19 guideline updates include evidence-based considerations for treatment of patients hospitalized with flu and COVID-19 coinfection.

The first study to compare COVID-19 and influenza complications in hospitalized patients found COVID-19 patients more likely to be admitted to ICU and to die.

The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.

The FDA has issued guidance for sponsors of requests for EUA for COVID-19 vaccines including details on clinical trial data required to support award of EUA.

From daily aspirin to RGN-CoV2 to zinc, the president of the United States has been treated for COVID-19 with a wide range of both authorized and unproven therapies.

Over half of antibiotic courses in a new study exceeded guideline-recommended minimum effective durations, translating to >54 million potentially excessive days.

The possibility of a flu season wrapped in a global pandemic may have health care professionals especially worried this year.

More than 10% of those who develop severe COVID-19 have misguided antibodies that derail the immune response, according to new research.

Worried about the upcoming flu season overlapping with COVID-19? Get up to date on available tests and the clinical aspects of the diseases with our quick article.

CEOs of 9 drug companies involved in COVID-19 vaccine development signed a pledge ensuring that sound science and ethics will guide the process.

The CDC estimates delivery of a record 194 to 198 million doses of influenza vaccine this year. The primary care imperative: vaccinate, vaccinate, vaccinate.

The AstraZeneca-Oxford University investigational coronavirus disease 2019 (COVID-19) vaccine candidate, has expanded into a phase 3 clinical trial.

Some symptoms of COVID-19 overlap with the common cold, flu, and other respiratory diseases. See if you can differentiate between them in these 5 patient scenarios.

Treatment guidelines on COVID-19 from the NIH were updated today based on data from clinical trials of hydroxychloroquine, ivermectin, and IL-6 inhibitors.

Approximately 67% of US adults are wary about trusting Russia’s Sputnik V COVID-19 vaccine without proof, according to a new survey of >30 000 Americans.

A Harris Poll finds Americans want a US-approved COVID-19 vaccine allocated here first, the rest of the world next, and our most vulnerable take priority.

The FDA issued an emergency use authorization for convalescent plasma for the treatment of COVID-19 in hospitalized patients.

VIDEO: NIH-funded infectious disease expert discusses convalescent plasma, remdesivir, corticosteroids, and the COVID-19 vaccine timeline.

Groups at high risk for influenza and its complications were less likely to receive vaccination while hospitalized vs the general population, according to a new study.

The COVID-19 pandemic makes timely catch-up vaccination against all vaccine-preventable diseases essential. Try these 5 questions on CDC recommendations.

Patients with severe obesity are 4-times as likely to die from COVID-19, a new study finds, with younger patients and men with obesity at highest risk.

Pneumococcal vaccine should still be given to adults aged ≥65 years, but no longer to all adults in that population. Find out what you know - and what you may need to know.